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ARTICLE OPEN
Parkinson’s disease patient-specific neuronal networks carrying
the LRRK2 G2019S mutation unveil early functional
alterations that predate neurodegeneration
G. Carola1,2,14, D. Malagarriga1,2,14, C. Calatayud 1,2,3,14, M. Pons-Espinal 1,2,14, L. Blasco-Agell1,2, Y. Richaud-Patin3,
I. Fernandez-Carasa 1,2, V. Baruffi 1,2, S. Beltramone1,2,4, E. Molina5, P. Dell’Era 4, J. J. Toledo-Aral6, E. Tolosa7, A. R. Muotri 8,
J. Garcia Ojalvo 9, J. Soriano 10,11✉, A. Raya 3,12,13✉ and A. Consiglio 1,2,4✉
A deeper understanding of early disease mechanisms occurring in Parkinson’s disease (PD) is needed to reveal restorative targets.
Here we report that human induced pluripotent stem cell (iPSC)-derived dopaminergic neurons (DAn) obtained from healthy
individuals or patients harboring LRRK2 PD-causing mutation can create highly complex networks with evident signs of functional
maturation over time. Compared to control neuronal networks, LRRK2 PD patients’ networks displayed an elevated bursting
behavior, in the absence of neurodegeneration. By combining functional calcium imaging, biophysical modeling, and DAn-lineage
tracing, we found a decrease in DAn neurite density that triggered overall functional alterations in PD neuronal networks. Our data
implicate early dysfunction as a prime focus that may contribute to the initiation of downstream degenerative pathways preceding
DAn loss in PD, highlighting a potential window of opportunity for pre-symptomatic assessment of chronic degenerative diseases.
npj Parkinson’s Disease            (2021) 7:55 ; https://doi.org/10.1038/s41531-021-00198-3
INTRODUCTION
Parkinson’s disease (PD) is the most common neurodegenerative
movement disorder, with an estimated prevalence in industria-
lized countries of 0.3% in the general population, which increases
to 1.0% in people older than 60 years and to 3.0% in people older
than 80 years1. Clinically, PD is characterized by classical motor
syndrome linked to a progressive loss of dopamine-containing
neurons (DAn) in the substantia nigra pars compacta, and
disabling non-motor symptoms related to extranigral lesions.
Current therapies for PD are symptomatic and do not limit the
progression of disability with time. It has been proposed that early
intervention might slow down or even stop disease progression,
by preserving neurons from the undergoing irreversible neurode-
generation1,2. However, early treatment relies on early diagnosis,
which unfortunately is especially complicated in the case of PD.
Current diagnostic modalities in PD are based on the presence of
motor symptoms, a stage at which up to 70% of DAn have been
lost3. Even though pre-motor symptoms are known to precede
clinical diagnosis of PD by as much as a decade, they are rather
unspecific and unsuitable as stand-alone biomarkers of the
disease4. Therefore, the identification of early diagnostic or
progression markers of PD represents an urgent medical need.
Although the majority of PD cases are of unknown cause, so-
called idiopathic PD, around 5% have been shown to have a
genetic basis, with mutations in the LRRK2 gene accounting for
the largest number of patients of familial PD5. Interestingly, LRRK2
polymorphisms are also considered a relevant genetic determi-
nant for sporadic PD6, and LRRK2 function appears dysregulated in
sporadic cases of PD7, even in the absence of LRRK2 mutations/
polymorphisms. These findings, together with the fact that PD
associated with mutations in LRRK2 (L2-PD) is clinically indis-
tinguishable from sporadic PD, position LRRK2 as an essential
player for understanding both genetic and idiopathic PD8. LRRK2
is a highly complex protein with multiple enzymatic domains,
involved in a variety of intracellular signaling pathways and
cellular processes such as cytoskeleton dynamics, vesicle traffick-
ing and endocytosis, autophagy, reactive oxygen species,
mitochondrial metabolism, and function of immune cells. How-
ever, the exact physiological role of LRRK2 and its implication for
PD pathogenesis remains unknown8.
Of especial relevance for the investigation of early disease
markers, transgenic mouse models of L2-PD display, before any
events of neurodegeneration, an abnormally elevated excitatory
activity and altered spine morphology in dorsal striatal spiny
projection neurons9. Moreover, experimental models for other
neurodegenerative conditions such as Alzheimer’s disease10,11
and amyotrophic lateral sclerosis12, have been shown to exhibit
neuron hyperexcitability before the disease onset. It has also been
demonstrated that the combination of PD with dementia often
correlates with a disruption of both functional and effective
connectivity in the cortex13. In contrast, the association of PD with
depression correlates with disrupted functional connectivity
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between the median cingulate cortex and the prefrontal cortex
and cerebellum14,15.
The development of induced pluripotent stem cell (iPSC)
technologies enables the generation of patient-specific, disease-
relevant, cell-based experimental models of human diseases.
Importantly, iPSC-based models can recapitulate some of the
earliest signs of disease, even at pre-symptomatic stages12,16. In
this study, we used an experimental platform based on DAn-
enriched neuronal cultures derived from L2-PD patients, their
gene-edited isogenic counterparts, or from healthy individuals.
Such cultures formed active neuronal networks, the functionality
of which was analyzed by calcium imaging. After multiple
iterations of experimental characterization and biophysical
modeling of neuronal network behavior, we could identify early
alterations in PD neuronal function that were not present in
control networks, and that predated the onset of neuron
degeneration.
RESULTS
Generation and characterization of iPSC-derived DA neurons
A total of seven iPSC lines representing L2-PD patients and healthy
aged-matched controls, along with gene-edited counterparts and
fluorescent TH reporters, were used for the current studies (see
Table 1 and “Methods” for further details). Some of these iPSC
lines have been previously generated and fully characterized in
our laboratories17–19, whereas two additional TH reporter lines
were generated for this study (Supplementary Fig. 1).
iPSC differentiation toward DAn fate was performed using a
modified version of the previously established midbrain floor-
plate protocol20, which enabled the maintenance of differen-
tiated cells for up to 10 weeks21. Briefly, we first cultured iPSCs on
Matrigel with mTeSR medium until they reached 80% con-
fluence, then we induced specification toward the ventral
midbrain (VM) fate using a combination of knockout serum
medium and neural induction medium (Fig. 1a). At day 12 post-
plating (D12) the cells exhibited a homogeneous morphology
and marker profile of VM floor-plate progenitors, expressing
FOXA2+/LMX1A+ and the VM NPC markers such as OTX2 and
EN1 paired with the neuroectodermal stem cell marker Nestin
(Fig. 1b). These progenitors were then cultured in neuronal
differentiation medium supplemented with growth factors
including BDNF, GNDF, TGF-β, and DAPT, with the aim to foster
neuronal differentiation and survival (Fig. 1a). At D50, the
majority of the cells were positive for the dendritic marker
MAP2, and quantitative immunolabeling for tyrosine hydroxylase
(TH) and FOXA2 revealed that 30–40% of them were also
committed to DA neuronal fate (Fig. 1c, d).
By the same day of differentiation (D50), about 35% of TH+
neurons also expressed the A9 domain-specific marker G protein-
activated inward rectifier potassium channel 2 (GIRK2) (Fig. 1c, d),
and displayed Dopamine Transporter (DAT), the essential marker
of mature DAn (Fig. 1e). TH+ neurons also showed expression of
pre-synaptic marker Synapsin and post-synaptic marker PSD95,
indicating their capability to form synapses (Fig. 1f). Under these
conditions, controls (CTR) and PD-iPSCs gave rise to VM DAn that
were morphologically homogeneous and showed the expected
features of mature VM DAn, including complex dendritic
arborization (Fig. 1g). Although the protocol used was comparably
effective in all iPSC lines analyzed, we found some variability in the
number of VM DAn across lines at D35, ranging from 10 to 20%
VM DAn ratio concerning all differentiated cells. This ratio did not
depend on the presence or type of disease (Fig. 1h). Instead, it
seemed related to the specific iPSC clone used and to the
evolution at the early stages of differentiation.
After establishing equivalent DAn-enriched cultures from both
control and patient iPSC lines, we evaluated whether there were
any differences in cell viability between DAn derived from controls
and patient iPSC lines. We first noted that control and L2-PD iPSC-
derived DAn were indistinguishable, based on immunofluores-
cence (IF) images (Fig. 1g) up to 80 days in culture, the latest
timepoint investigated. By counting the number of TH-expressing
cells (Fig. 1h) we found no decline when cultured over time up to
D80, strongly suggesting that DAn are not degenerating under
these conditions (Fig. 1g, h). We also found no differences in the
percentage of cells with pyknotic nuclei in patient lines compared
to control lines (data not shown; D50: 12–15% in all the lines; D80:
15–20% in all the lines).
We next analyzed whether changes in transcriptome profiles
suggestive of neurodegeneration appeared under these condi-
tions. For this purpose, we measured the expression of a panel of
770 genes relevant for this process (NanoString Human Neuro-
pathology Panel) in neuronal cultures differentiated from control
and L2-PD iPSC at D50. Independent differentiation experiments
from the same iPSC lines displayed highly similar gene expression
profiles (Fig. 1i, Supplementary Fig. 2a), highlighting the robust-
ness of the differentiation protocol. A comparison of gene
expression levels between control and L2-PD cultures identified
157 differentially-expressed transcripts with ≥2-fold change (50
upregulated and 107 downregulated), but no differences reached
statistical significance with p-Adj ≤ 0.1 (Supplementary Dataset),
nor did they correlate with PD-related hallmarks (Supplementary
Fig. 2b–d). Thus, even though previous studies have found overt
signs of neurodegeneration upon long-term culture of DAn
differentiated from L2-PD iPSC17,18,22,23, under the culture condi-
tions used in the present work (that include neurotrophic factors),
they appeared to form overall healthy neuronal cultures similar to
the ones generated by control iPSC.
Characterization of neuronal activity
Calcium activity recordings were then performed across all the
seven independent lines to examine the functional maturity of the
iPSC-derived neuronal networks after 35, 50, and 80 days of
differentiation (D35-D50-D80) (Fig. 2a). We noted that our calcium
fluorescence assay enabled tracking the behavior of ~500 neurons
in the field of view with a high spatial and temporal resolution,
allowing us to resolve single cells and their dynamic interactions.
Table 1. Summary of the healthy controls and patients used in this study.
Cell line code Status Code used in this study Sex Age at donation Age at onset LRRK2 mutation Isogenic control
SP-11 Control CTR F 48 No
SP-11TH Control CTR TH F 48 No
SP-12wt/wt Isogenic Control isoPD1 F 63 G2019S LRRK2G2019S corrected
SP-12 L2-PD PD1 F 63 49 G2019S
SP-12TH L2-PD PD1 TH F 63 49 G2019S
SP-12THwt/wt Isogenic Control Iso PD1TH F 63 G2019S LRRK2G2019S corrected
SP-13 L2-PD PD2 F 68 57 G2019S
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Sharp increases in the fluorescence traces (Fig. 2a) revealed
spontaneous neuronal activations, which were analyzed to extract
the onset times of elicited action potentials. With these data we
first computed the average neuronal activity along culture time
(Fig. 2b) and observed that all lines evolved similarly, indicating
that any anomalies in PD networks would depend on the structure
of the activity patterns, rather than on the strength of activity
itself. Thus, we next computed the Global Network Activity (GNA),
Fig. 1 Generation of ventral midbrain (VM) dopaminergic neurons from human iPSCs. a Scheme showing VM dopaminergic neurons
differentiation protocol. b Representative immunofluorescence (IF) images of CTR (SP11) and PD1 (SP12) NPCs at day 12 of the differentiation
process. iPSC-derived neural cultures express floor plate progenitor markers, such as Lmx1A, FoxA2, Otx2, Nestin, and EN1. c Representative IF
images of CTR (SP11) and PD1 (SP12) differentiated neuronal cultures expressing neuronal markers (MAP2, TH) and midbrain-type DA markers
(FoxA2 and Girk2) at day 50. Scale bar is 50 μm. d Percentage of TH/FoxA2 and TH/Girk2 vmDAn at day 50 of all the lines [CTR (SP11), CTR TH
(SP11 TH), gene-edited isoPD1 (SP12 wt/wt), PD1 (SP12), PD1 TH (SP12 TH), PD2 (SP13)]. A number of independent experiments n= 3.
e–f Representative images of neuronal cultures at D50 expressing specific markers of maturation: e DAT (dopamine transporter) (scale bar,
50 μm); and f PSD95 (post-synaptic marker, red) and synapsin (synaptic marker, green). Orthogonal views show colocalization (scale bar,
10 μm). g Representative images of CTR (SP11) and PD1 (SP12) neuronal culture at D35-D50 and D80 showing the expression of TH and MAP2
markers at the different timepoints. h Percentage of TH+ cells over DAPI at the three different timepoints (D35-D50 and D80). i Heatmap of
gene expression profiles of neuronal cultures of CTR (SP11), PD1 (SP12), PD2 (SP13), and gene-edited isogenic PD1 line (isoPD1) at D50, with
dendrograms showing the strong similarities between independent experiments and the absence of clustering between control (CTR and
isoPD lines, light brown) and PD (PD1 and PD2 lines, blue) conditions. Shown are transcripts with ≥2-fold change in expression, grouped as
upregulated (50 transcripts, green bar) or downregulated (107 transcripts, purple bar). No statistically significant differences were found at
p-Adj ≤ 0.1 when comparing control and PD conditions. Each type of culture was analyzed a minimum of 2 independent times, except for the
gene-edited isogenic PD1 line, for which only one RNA preparation passed the quality control and could be analyzed.
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defined as the fraction of neurons in the network that coactivated
in a time window of 1 s. As shown in Fig. 2c, the GNA captures the
level of neuronal synchronization present in the raster plot. For
control cultures and also for the rescued isogenic PD line (left and
central panels), collective activity encompassed synchronous
activations of moderate size, between 10 and 40% of the network.
In contrast, PD neuronal cultures (Fig. 2c, right panels) displayed a
two-state dynamics, with strong whole-network synchronous
events combined with quiescent intervals. Importantly, the
distinct GNA patterns of control and PD neuronal cultures hint
at the existence of intrinsically different network mechanisms in
the two systems, which orchestrate a markedly different collective
behavior. The GNA also informed that average neuronal activity
by itself was not sufficiently informative to reveal alterations due
to disease.
To quantify the differences between cell lines exposed by the
GNA analysis, we next analyzed the amplitude of the GNA events
and extracted those that exceeded a given threshold (Fig. 2c, red
dotted line), termed ‘extreme event’. We observed that the ‘ratio
of extreme events’, i.e., the number of large bursting episodes
relative to all detected episodes, was much higher in PD lines than
in CTR or in genetically-corrected isogenic control (isoPD) lines,
particularly at late stages of maturation (D80) (Fig. 2d), which
could render them more susceptible to stress by creating an
overly rigid, synchrony-locked network despite their continued
viability in culture.
Functional connectivity of control and PD neuronal networks
The different structure of global activity of CTR, isoPD, and PD lines
hints at the existence of distinct functional connectivity traits
between them. To shed light on network functionality, we used
transfer entropy (see “Methods” for details) to compute the
functional connectivity among all pairs of active neurons in a
given network. As shown in Fig. 3a (top panels), the functional
networks displayed abundant connections, with a combination of
short-range and long-range links that extended across the
network. Even though the functional networks seemed similar in
spatial organization, we observed significant differences between
control and PD networks. The first difference was a lower density
of connections in the PD line, suggesting an overall degradation of
functionality. A second difference concerns the structure of
functional communities, i.e., groups of neurons that tend to
connect among themselves more strongly than with the rest of
the network. As shown in the bottom panels of Fig. 3a, functional
communities were abundant in CTR and isoPD cultures (high-
lighted blue boxes), indicating cross-talking of neurons in small
groups, in agreement with the moderate size of collective
activations. For PD cultures, however, the communities were
Fig. 2 Network dynamics of vmDA neurons. a Representative image of a bright field recording at D80 (isoPD1) using the calcium imaging
assay. Scale bar is 100 μm. Regions of interest were manually selected for each neuron (diameter 10 μm; color circles) to obtain the normalized
calcium fluorescence time series of spontaneous activity, DFF (%) 100  ðF  F0Þ=F0, with F0 the fluorescence signal of the neuron at rest. The
green box illustrates the fast rise of fluorescence upon activation that procures the spiking onset time (arrowhead). The dashed black boxes
illustrate coordinated neuronal activity that shape network bursts when several neurons are involved. b Average neuronal activity along
maturation for the different cell lines. Data points are expressed as mean±SD. Trend lines are linear regressions. The number of cultures used
in each condition and timepoint were: D35 (CTR: n= 3; isoPD1: 3; PD1: 4; PD2: 4); D50 (3; 9; 9; 5); D80 (3; 9; 8; 5). c Representative raster plots
(top) and global network activity (GNA, bottom) for CTR (SP11), isoPD1, and PD1 (SP12) neuronal cultures at D80. Each plot shows 5min of
recording. Peaks in the GNA reveal network bursts (blue dots). Extreme bursting events (red dots) are those that are above a threshold (red
dotted line) set as 95% confidence interval of CTR bursts’ distribution. CTR and isoPD1 networks show a relative low percentage of extreme
events, which contrasts with the rich abundance of them in PD1 networks. d Ratio of extreme events for all studied cell lines at D50 and D80.
The colored boxes are a guide to visualize the distributions, which show the mean ± SD and the individual realizations (dots). For panels (b)
and (d), the number of independent experiments for each condition and timepoint are D35 (CTR: n= 3, isoPD1: 3, PD1: 4, PD2: 4); D50 (3, 9, 9,
5); D80 (3, 9, 8, 5). ***p < 0.001 (ANOVA with multiple comparison analysis).
G. Carola et al.
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Fig. 3 Functional connectivity of CTR, isoPD, and PD lines. a Top, Representative functional connectivity maps at D80 for CTR, isoPD1, and
PD1 cultures. Dots are neurons and lines functional connections. The diameter of a dot and its opacity is proportional to the connectivity of
the neuron it represents. Bottom, corresponding functional connectivity matrices. Black points are functional connections and colored boxes
are functional communities. b Comparison of the number of communities and community statistic Q for the three lines at D50 and D80. PD1
networks are excessively integrated, with a relatively small number of communities strongly interconnected (low Q) as compared to CTR and
isoPD1 networks. The colored boxes are a guide to visualize the distributions, which show the mean±SD and the individual realizations (dots).
Number of independent experiments: D50 (CTR: n= 3, isoPD1: 4, PD1: 6); D80 (3, 5, 6). ****p < 0.001; **p < 0.01; *p < 0.05 (ANOVA with multiple
comparison analysis). c Sketch of functional differences between normal and PD networks according to the data, with PD networks displaying
on average a lower connectivity combined with fewer and excessively connected communities. d Cumulative distribution functions (CDF) of
functional connections (in % of network) at D50 for CTR, PD1, PD2, and gene-edited isogenic PD1 line (isoPD1). The CDFs of the two PD lines
exhibit a trend toward a lower connectivity as compared to CTR and isoPD1 ones, which are similar. e Corresponding distributions at D80. The
two PD lines maintain their low connectivity profiles and strengthen their differences relative to CTR and isoPD1, which remain similar. The
number of independent experiments used in panels (d) and (e) are D50 (CTR: n= 3, isoPD1: 4, PD1: 6, PD2: 5); D80 (3, 5, 6, 5).
G. Carola et al.
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much larger (orange boxes), indicating not only a failed formation
of functional microcircuits, but a tendency toward excessively
strong network synchronicity, as also seen in the raster plots.
These results were reproducible across realizations. As shown in
Fig. 3b, PD networks exhibited a clear trend toward a small
number of communities, which was accompanied by a tendency
toward a stronger bond between these communities, i.e., an
abnormal excessive integration. The latter was captured by the
‘community statistic Q’. The lower the Q value, the stronger the
integration in the network. These differences appeared at D50 and
substantially strengthened at D80. While CTR and isoPD cultures
showed a moderate integration, PD cultures exhibited an
abnormally strong integration. The combination of these results
is summarized in Fig. 3c, which depicts two toy networks with the
same number of neurons but with different functional organiza-
tion. The normal, healthy network is characterized by a high
average connectivity and well-defined small communities, while
the PD network is characterized by a lower average connectivity
and large, strongly linked communities that effectually almost
shape a unique structure.
To complete the functional analysis, we compared in more
detail the statistics of functional connections. Figure 3d, e shows,
for D50 and D80 stages of development, the cumulative
distribution function of connections, CDF(k), for control, isoPD,
and PD lines. This distribution portrays the probability that a
neuron in the network has a number of connections less or equal
than k. For D50, all distributions were similar and relatively close to
one another, illustrating that they originated from similar
dynamics, namely a combination of individual activity and
network bursting. The distributions also showed a subtle growth,
indicating that weakly connected neurons were rare. However, the
PD distributions at D50 revealed a tendency toward a lower
connectivity. Indeed, although the distributions were similar in
shape, an analysis of the distance between distributions
(Kullback–Leibler divergence and Kolmogorov–Smirnov test, Supp.
Fig. 3) showed statistical differences among them, indicating that
D50 could be the characteristic timepoint at which functional
alterations in PD lines start to be detectable. The differences
among distributions accentuated at D80, with PD cultures
exhibiting a more pronounced trend toward a lower connectivity
(a sharp increase of CDF(k) at low k values) that markedly departed
from CTR and isoPD cultures. Interestingly, there were no
statistically significant differences between CTR and isoPD cultures
at this timepoint, a result that suggests the successful rescue of
affected cell lines through correction of the LRRK2 mutation by
gene edition.
In light of these results, we considered the control network as
the reference for a healthy development and function, and the
departure from it as a signature of the pathology. Thus, we
hypothesize that the LRRK2 mutation undermines the develop-
ment of neuronal circuitry to such an extent that it alters collective
network activity and functional organization.
Contrasting dynamics of TH and non-TH neurons in control
and PD lines
To investigate the origin of the functional impairment found in PD
DAn, we took advantage of the genetic TH-reporter tool created in
our lab19. This reporter allows identifying TH and non-TH neuronal
populations in the networks and analyzing their functional
characteristics separately. Figure 4a, b exemplifies such a
construction for representative isoPD and PD networks at D80,
in which two neuronal layers, one corresponding to TH neurons
(red) and another one corresponding to non-TH neurons (blue),
interact functionally. The spontaneous activity of each subpopula-
tion of neurons at D80 is shown in the accompanying raster plots.
A comparison of the activity patterns between isoPD and PD
cultures reveals the strong contrast in their dynamics. While the
non-TH population in isoPD cultures shows a sustained activity
with weak collective events, PD cultures show strong synchrony
episodes that extend to both subpopulations.
In addition, as shown in Fig. 4c, a comparison of the ratio of
extreme events for TH and non-TH subpopulations indicates that,
on average, PD cultures exhibited a higher number of extreme
events in both subpopulations when compared to controls.
However, along development, TH and non-TH ratios for controls
were similar at D50 and D80, whereas the ratios for the PD line
switched from mostly TH at D50 to mostly non-TH at D80.
Altogether, these results unfold an abnormal subpopulation
dynamics in PD networks, with an overall excessive bursting and
a reversing leadership of TH and non-TH subpopulations along
development. We also noted that PD cultures at D50 showed
important variability among realizations, with extreme events in
the non-TH population being absent in some experiments and
abundant in others. Given this variability, we hypothesize that the
D50 timepoint might mark the onset of structural alterations that
later translate into dynamic and functional deficits.
Since about 70% of the neurons in our networks are non-TH
(Fig. 1g, h), the above results suggest that, in healthy control
cultures, non-TH neurons drive spontaneous activity in the
network. In contrast, TH neurons play a regulatory yet essential
role by facilitating the coexistence of small neuronal coactivations
and whole-network bursting events. This regulatory role appears
to be lost in PD cultures, in which TH neurons frame spontaneous
activity patterns with excessive synchrony that translate into an
abundance of extreme bursting episodes. We, therefore, hypothe-
size that the LRRK2 mutation alters the balance between neuronal
subpopulations by degrading the physical coupling among
neuronal types.
An in silico model captures the dynamic alterations in PD
networks
Next, we carried out numerical simulations to better understand
the impact of TH+ cells structural failure on PD network dynamics.
Specifically, we evaluated whether a reduction in TH cells
connectivity was sufficient to switch global network dynamics
from balanced to excessively synchronous.
We first reproduced the behavior of control networks. As shown
in Fig. 5a, we used the same neuronal spatial arrangement of the
cultured networks and considered a mixed population of 55%
excitatory non-TH neurons, 25% excitatory TH+ neurons, and 20%
inhibitory neurons. These values were selected to concord with
both the typical 80% excitation of cortical circuits in vitro24 and
the TH/DAPI ratio found in our cultures (Fig. 1). Neuronal dendritic
trees and axons were then incorporated according to realistic
biological rules, so that a connection was established whenever an
axon crossed the dendritic tree of a neuron (Fig. 5b, top). Once the
network structure was set, dynamics was incorporated through an
extended Hodgkin–Huxley model with parameters adjusted to
replicate the activity in controls. As shown in the top panels of Fig.
5c, normal network dynamics was qualitatively similar to the
experiments shown in Fig. 2c (left and center) and characterized
by an intense background activity in combination with coordi-
nated activity episodes. The inspection of the different popula-
tions (Fig. 5c, top, right panels) shows that non-TH neurons were
also the drivers of network dynamics. It should be noted that
inhibition was necessary in the simulations to ensure a sufficiently
high spontaneous activity.
To explore PD dysfunction, we used the same control networks
and modeled the shortening of neurites in TH neurons, effectually
reducing the connectivity probability in the TH population (Fig. 5b,
bottom). Such a construction signified that a single TH cell lost
about 80% of its connections. We then explored the minimum
fraction of TH cells that had to be affected to observe an impact
on the network dynamic. As shown in the bottom panels of Fig.
G. Carola et al.
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5c, PD simulations were characterized by an exceedingly
synchronous behavior that captured well the experimental
observations of PD cultures (Fig. 2c, right), with a much lower
background activity and a similar dynamic in both TH and non-TH
populations. Simulations also demonstrated that the affectation of
~10% TH cells sufficed to drive the networks toward a chronic
bursting behavior with an abundance of extreme, whole-network
synchronous events (Fig. 5c). As shown in Fig. 5d, we compared
three different ratios of affected TH neurons. An increase in this
ratio mimics disease progression, i.e., developmental time in the
experiments. The results show that the ratio and occurrence of
extreme events are similar for different damage rates, possibly
because the remaining excitatory and inhibitory neurons are
sufficiently large to maintain activity. Interestingly, these results
also indicate that a small damage suffices to drive the network
toward an excessively synchronous scenario. Finally, an analysis of
functional connectivity showed that the model also reproduces
well the experimental observations, with a tendency for simulated
PD cultures to shift toward lower connectivity states (Fig. 5e).
TH+ neurons carrying LRRK2 mutation feature a lower
number of dendrites
To verify the prediction of the in silico model above and expose
physical alterations in the circuitry of PD lines, we investigated the
morphology of TH neurons in CTR, isoPD, and PD neuronal
cultures at D50 and D80 (Fig. 6a and Supplementary Fig. 4a). We
found that DAn differentiated from PD iPSC lines showed a lower
number of TH neurites compared to those derived from CTR or
isoPD lines (1.2 ± 0.1 neurites for PD vs. 4.5 ± 0.2 for CTR and 4.1 ±
0.3 for isoPD, Fig. 6b). In addition, the number of neurites in CTR
and isoPD cultures increased along with development while it
decreased in PD cultures, indicating a progressive deterioration of
network structure for the latter (Fig. 6b). In contrast, the number of
neurites in MAP2+ neurons from control, isoPD, and PD lines did
not show any significant differences (Fig. 6c), confirming that the
dynamic and functional deficits of PD lines are localized to the TH
subpopulation, and that these cells experience a gradual structural
failure in the form of neurite loss.
Next, we evaluated DA release in the media collected from CTR,
isoPD, and PD neuronal cultures. Supernatants of PD cultures
revealed decreased dopamine levels at D50 and D80 compared
with those of CTR and isoPD cultures (Fig. 6d), indicating that the
reduction in TH+ neurites has functional consequences on DA
release. Finally, to investigate whether the early sign of overall
alteration in the network structure and dynamics could contribute
to neurodegeneration, we maintained iPSC-derived DAn over
culture times longer than D80. Interestingly, in aged (110 days,
latest timepoint analyzed) cultures, PD DAn showed morphologi-
cal alterations, including reduced number and length of neurites,
and significantly decreased cell survival compared with isoPD DAn
(Supplementary Fig. 5a–d). In contrast, neuronal degeneration was
Fig. 4 Functional connectivity and dynamics of TH+ and non-TH+ neurons. a Left, representative functional network of an isoPD1 culture
at D80, signaling the location of TH+ neurons (red) and non-TH+ neurons (blue). The diameter of a dot is proportional to the connectivity of
the neuron it represents. Only 10% of the connections are shown for clarity. Right, corresponding raster plots of the two populations.
b Corresponding analysis for a PD1 culture, in which the non-TH+ subpopulation exhibits a much stronger synchronous behavior as
compared to controls. c Ratio of extreme events for each subpopulation of neurons at two maturation stages, D50 and D80. PD cultures show
in general a higher ratio of extreme events as compared to controls. The non-TH+ population in the PD network at D50 shows a strong
variability in the ratio of extreme events across realizations, indicating the onset of malfunction. The same population at D80 is dominated by
extreme events that reflect the strong synchronous behavior. The colored boxes are a guide to visualize the distributions, which show the
mean ± SD and the individual realizations (dots). The number of independent experiments in panel (c) are D50 (CTR: n= 3, isoPD1: 5, PD1: 5);
D80 (3, 5, 5). ***p < 0.001; **p < 0.01; *p < 0.05 (ANOVA with multiple comparison analysis).
G. Carola et al.
7
Published in partnership with the Parkinson’s Foundation npj Parkinson’s Disease (2021)    55 
not evident in non-TH+ cells, as judged by the percentage of
MAP2+/TH− neurons in the neuronal cultures (Supplementary
Fig. 5e).
DISCUSSION
Since early diagnosis of PD is expected to dramatically improve
the outcome of therapies under current development, in the
present study we interrogated a human neuronal cell-based
model of PD for the earliest detectable functional alterations. We
found that DA neurons derived from iPSC representing healthy
individuals or PD patients harboring LRRK2 mutation developed
appropriate physiological characteristics forming complex and
mature networks during the differentiation process. However, PD
neuronal networks developed abnormal hypersynchrony at the
latest timepoint analyzed (D80), in contrast with healthy or gene-
edited isogenic PD networks. These new data from PD-affected
human DAn indicate that early dysfunction may contribute to the
initiation of downstream degenerative pathways that ultimately
lead to DAn loss in PD. A general limitation of human iPSC-based
disease modeling strategies that should be taken into account
when interpreting the results of our studies is the notorious
Fig. 5 Numerical simulations of normal and PD networks. a Representative CTR culture at day 80, used as a reference for the spatial
allocation of neurons in the numerical model. The enlarged area depicts a detail of the neuronal spatial arrangement. 300 neurons are used in
the simulation, and are randomly assigned as dopaminergic (DA, red, 25% of network), inhibitory (green, 20%), and excitatory (blue, 55%).
b Random pruning algorithm, in which PD damage is simulated by a shortening of either axons (red curve) or dendritic arbor (dotted red
circle) in DA neurons (red hexagons). In the sketch, normal connectivity is established when the dendritic arbor of any neuron (dotted circles)
intersects an axon. Neurite pruning disconnects neurons either because of axonal shortening (neuron #1) or dendritic loss (neuron #2) in DAn.
c Raster plots of simulated normal and PD networks, with the latter corresponding to an axonal pruning on 10% of DA neurons, each one
losing about 80% of connections. In the raster plots, the left panels show the dynamics of the entire network, whereas the right panels show
the dynamics in each subpopulation. All raster plots range from 0 to 300, but the number of active neurons in each plot vary according to the
population monitored. PD simulations show a markedly synchronous behavior of the excitatory population that translates onto the entire
network. d Ratio of extreme events for different percentages of pruned DAn subpopulation, showing that the presence of extreme bursting
events increases as network affectation progresses. The colored boxes are a guide to visualize the distributions, which show the mean ± SD
and the individual realizations (dots). The number of individual simulations is n= 4 for each condition. ***p < 0.001; *p < 0.05 (ANOVA with
multiple comparison analysis). e Cumulative distribution of functional connections (CDF) for two PD networks (at 10 and 30% pruning) and a
normal, non-pruned network. The distributions show the same trend as in the experiments, with PD departing from normal toward a low
degree functional connectivity scenario.
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variability described among iPSC lines and clones25. To rule out
the impact of interline/interclone variability in our findings, we
used several iPSC lines and iPSC clones to represent each
experimental condition. Specifically, controls included two inde-
pendent iPSC lines generated from two independent individuals,
and a total of four iPSC clones, whereas the PD condition was
similarly represented by two independent iPSC lines generated
from two independent individuals, and a total of three iPSC clones
(Table 1). Moreover, the confirmation of our findings in neuronal
cultures differentiated from gene-edited isogenic controls of PD
iPSC provides further reassurance that the alterations identified in
PD samples in our studies are indeed related to the disease
condition, rather than reflecting the specific iPSC line/clone
utilized.
Our previous work showed that PD patient-specific iPSC-derived
DAn are particularly susceptible to undergo neurodegeneration
Fig. 6 Biological confirmation of the in silico hypothesis. a Gene-edited isoPD1 (SP12 wt/wt) and PD1 (SP12) TH+ neuronal processes are
traced (orange) to determine the number and the structure of neurites at D50 (left panels) and D80 (right panels). The top panels for each cell
line show the original image of TH+ neurons. A blue triangle highlights a representative traced neuron shown in the middle panels. The
bottom panels for each cell line show MAP2+ neuronal processes. Scale bar is 50 μm in all images. b The quantification of the number of TH
neurites shows significant differences between CTR and PD1 both at D50 and D80. c No differences are detected on the number of MAP2
neurites. d Levels of released DA measured in culture media from CTR (SP11), PD1 (SP12), PD2 (SP13), and isoPD1 (SP12 wt/wt) at D50 and D80
of differentiation, relative to CTR levels. *p-value < 0.05; **p-value < 0.01; ***p-value < 0.001 (ANOVA with multiple comparison analysis).
Number of independent experiments n= 3.
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upon long-term culture17,18,23,26. In those studies, DAn were
differentiated from iPSC and then maintained in culture in the
absence of neurotrophic factors, which resulted in evident signs of
DAn neurodegeneration only in PD samples, after 75 days in
culture. For the present study, we used a different protocol for the
generation and maintenance of iPSC-derived DAn in culture,
which included neurotrophic factors and allowed comparing the
function of mature DAn from PD and control iPSC in the absence
of neurodegeneration for up to 80 days. Following these
conditions, we used a calcium fluorescence imaging assay to
monitor the functional neuronal activity of control and L2-PD
iPSC-derived DAn at different timepoints of differentiation. We
found that DAn derived from control iPSC exhibited an increase in
both the number of spontaneous activity events and the number
of bursting episodes, i.e., network-spanning synchronous activa-
tions. Such a trend is the one that could be expected from
maturing healthy iPSC-derived neurons in vitro27. Conversely, L2-
PD iPSC-derived DAn showed a two-state dynamic completely
different from controls, characterized by strong synchronous
events combined with quiescent intervals. The dynamics of PD
cultures suggests that the structure of collective activation —but
not the average individual neuronal activity—was the critical
feature of PD malfunctioning neuronal behavior. This apparent
sign of functional alterations was only displayed by the diseased
neurons at a late timepoint. Early in development, both control
and PD neuronal cultures showed similar functional behavior,
indicating that there is a defined period of time in which PD
network development starts to degrade and functional deficien-
cies emerge. The proportion of control iPSC-derived DAn in each
of the cell lines remained unchanged along the ten weeks of
culturing. Thus, despite remaining viable in culture, PD-affected
DAn failed at procuring the necessary structural support for a rich
collective dynamic and brought the network toward an exces-
sively synchronous state.
We introduced the connectivity probability of the TH popula-
tion into a biophysical model to address the role of neurite
connectivity. Numerical simulations of the model revealed that
neurite density loss in DAn was among the first causes of dynamic
and functional alterations. A random neurite loss in 10% of DAn
sufficed to render a bursting-dominated dynamic and an
excessively connected functional network. Our experimental data
confirmed the reduction of neurites specifically in DAn of PD
neuronal cultures. Thus, even though the culture conditions used
in the present studies prevented the appearance of overt signs of
PD DAn neurodegeneration observed in previous works using
more standard culture conditions17,22,28, they could not prevent a
slight reduction in PD DAn neurites. Therefore, it is important to
note that this phenotype appears to be independent from
differentiation and culture methods, depends on the presence
of the LRRK2G2019S mutation (inasmuch as it is absent in gene-
corrected isogenic PD DAn), and underlies the functional
alterations in overall network dynamics. It is tempting to speculate
that this observation might be related to the recent finding that
the LRRK2-G2019S mutated protein interferes with microtubule-
based motors29.
Previous studies of PD patients15 and animal models of the
disease9 have reported early hyperexcitability of DAn and
corticospinal neurons of the motor cortex. In our study, we
demonstrate that DAn derived from patient iPSC harboring LRRK2
mutations exhibit hyperexcitability in culture. This increased
activity might contribute to trigger a cascade of excitotoxic
disease mechanisms involving pathological changes in Ca2+
handling and the eventual activation of cell death pathways. In
contrast, recent work supports a link between hyperexcitability
and neuroprotection30,31, in particular when hyperexcitability is
induced via reduction of neurite density and a consequent lack in
connections and communication between neurons. This connec-
tivity loss may trigger compensatory mechanisms in which the
neurons create an aberrant structural and functional connectivity
that can be pointed as an early marker of pathology32,33. To
determine the actual role of hyperexcitability in PD, it will be
necessary for future studies to examine the effects of finely
controlled manipulations of excitability on human DAn.
Thus, dysfunction of DAn physiology appears to precede the
functional alterations that are then spread in the overall culture,
placing DAn dysfunction as an early sign of overall alteration and
neurodegeneration. Moreover, we directly connected this altera-
tion to a reduction in the neurite arborization using both
experimental data and in silico analysis. Taken together, these
findings highlight the importance of addressing early changes in
mechanisms underlying spike generation at the DAn soma when
considering disease pathogenesis and potential treatment strate-
gies for PD. Furthermore, our findings show the usefulness of
sensitive physiological studies of human iPSC-derived DAn for
future work aiming to develop new diagnostic tools and
therapeutics for PD.
METHODS
iPSC lines and gene editing
The parental iPSC lines used in our studies were previously generated and
fully characterized17–19. The generation and use of human iPSCs in this
work were approved by the Spanish competent authorities (Commission
on Guarantees concerning the Donation and Use of Human Tissues and
Cells of the Carlos III National Institute of Health). All procedure adhered to
internal and EU guidelines for research involving derivation of pluripotent
cell line. All subjects gave informed consent for the study using forms
approved by the ethical Committee on the Use of Human Subjects in
Research at Hospital Clinic in Barcelona. The iPSC lines used in this study
include one iPSC line obtained from a healthy donor (SP11) and two lines
obtained from PD patients carrying the LRRK2 G2019S mutation (SP12 and
SP13). From these original lines, isogenic controls solely differing in the
presence of the LRRK2 G2019S mutation were obtained by correcting the
LRRK2 mutation in the SP12 iPSC line. Expanded subject information, cell
characterization, and technical details of the original iPSCs are described
in Table 1.
Generation of CRISPR/Cas9 plasmids and donor template for
homology-directed repair
For correcting the LRRK2 mutation, LRRK2 G2019S mutant SP12 iPSC were
edited using TALENs. The CRISPR/Cas9 plasmid pSpCas9(BB)-2A-GFP
(PX458) was a gift from Dr. Feng Zhang (Broad Institute, MIT; Addgene
plasmid #12345)34. The original pCbh promoter was exchanged for the full-
length pCAGGS promoter to achieve higher expression levels in hiPSCs.
Custom guide RNAs were cloned into the BbsI sites as annealed
oligonucleotides. The donor template for HDR was generated using
standard molecular cloning procedures. Briefly, for TH donor template,
homology arms were amplified from genomic DNA and verified by Sanger
sequencing. Resulting sequences matched those of the reference genome
GRCh38. The homology arms were inserted into the KpnI-ApaI (5′HA) and
SpeI-XbaI (3′HA) sites of pBS-SK (− ). The sequence coding for the P2A
peptide was added to mOrange with the primers used to amplify the gene
and the PCR product was inserted into the ApaI-XhoI sites of the pBS-5′HA-
3′HA plasmid. Finally, LoxP-pRex1-Neo-SV40-LoxP was amplified from the
aMHC-eGFP-Rex-Neo plasmid (gift from Dr. Mark Mercola; Addgene
plasmid #21229)35 and inserted between the XhoI-SpeI sites of the
plasmid. For LRRK2 donor template, homology arms were amplified from
genomic DNA of a wild-type donor and verified by Sanger sequencing. The
homology arms were inserted in the KpnI-XhoI (5′HA) and SpeI-NotI (3′HA)
sites of pBS-SK (− ). LoxP-pRex1-Neo-SV40-LoxP was inserted in a second
cloning step between the SalI-BamHI sites.
Gene edition in iPSC
To generate the TH-mOrange hiPSC reporter cell line, cells were
transfected with the HDR template and a Cas9- and gRNA-encoding
plasmid; the latter overlapping the TH gene stop codon. In total, 800,000
iPSCs were seeded in 10-cm plates the day before transfection. iPSCs were
co-transfected with 6 µg of CRISPR/Cas9 plasmid and 9 µg HDR template
using FuGENE HD (Promega) at a 1:3 DNA to reagent ratio. Cells were
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plated in selection medium containing 50 µg/mL G418 (Melford Labora-
tories Ltd., Ipswich, UK) and maintained for 2 weeks until resistant colonies
could be screened. At that time, one-half of each resistant colony was
manually picked and site-specific integration was verified by PCR. To
correct the LRRK2 G2019S mutation in the SP_12 iPSC line, cells were
transfected with the wild-type HDR template and a Cas9- and gRNA-
encoding plasmid whose gRNA overlapped the insertion site for the
selection cassette. Transfection, clone selection, and subsequent screening
were conducted as described above. To excise the selection cassette,
edited iPSCs were transfected with a CRE recombinase-expressing plasmid,
gifted from Dr. Michel Sadelain (Sloan Kettering Institute; Addgene plasmid
#27546)36. At 48 h post-transfection, cells were dissociated and seeded at
clonal density on a feeder layer of irradiated human fibroblasts. When
colonies attained a certain size, they were picked and subcultured in
independent Matrigel-coated wells. Cells were sampled and checked for
cassette excision by PCR and Sanger sequencing. Those clones in which
the cassette was excised were expanded, cryopreserved, and karyotyped.
Expanded information regarding oligonucleotides used during gene
editing procedures are listed in Supplementary Table 3 in Supplementary
Information.
iPSC differentiation into vm DA lineage
Directed differentiation of iPSC onto ventral dopaminergic neurons (DAn)
was carried out following a previously published protocol20, with minor
modifications. Briefly, iPSCs were cultured in mTeSR commercial medium
until they reached 80% confluence. Ventral midbrain induction was then
forced by switching to SRM medium (KO-DMEM,15% KO serum, 1% P/S,
1% glutamine, 1%NEAA, 0.1% bet- mercaptoethanol) with SB Tocris 1614 (a
selective inhibitor of the growth factor TGF-b), LDN193189, Stemgent 04-
0074 (BMP inhibitor) to inhibit the dual SMAD pathway, SAG and
Purmorphamine, Calbiochem 540220 (SHH pathway activators) to induce
neuroepithelial stem cells formation and proliferation. The medium was
next changed to Neurobasal with 1% P/S, 1% N2, and 2% B27-VitA and
CHIR99021, Stemgent 04-0004 (CHIR), a potent GSK3B inhibitor known to
strongly activate WNT signaling that induces LMX1A in FOXA2 ventral
midbrain (VM) dopaminergic neurons precursors. The best co-expression
of LMX1A and FOXA2, crucial factors for inducing ventral midbrain fate,
was obtained at day 12 of differentiation. After generating and
characterizing the VM precursors, these cells were cultured in Neurobasal
medium, 1% P/S and 2% B27-VitA with neurotrophic factors: 20 ng/ml of
BDNF (450-02, Peprotech), 20 ng/ml of GDNF (450-10, Peprotech), 1 ng/ml
of TGF-B3, (R&D Systems 243-B3), Ascorbic acid (Sigma A-4034), 0.5 mM of
dbcAMP (D0627-25MG, SIGMA), and 5 µM of DAPT (565770; Calbiochem).
On day 20, the precursors were split into wells previously coated with Poly
Ornithine (15 µg/ml)/human Laminin (1 g/mL) and Fibronectin (2 µg/mL).
Cells were differentiated for additional 15, 30, and 60 days, finally
providing the timepoints states in the main text of 35, 50, and 80 days.
Studied cultures were fixed with PFA 4% and characterized for VM
specificity.
Immunocytochemistry
The differentiated cultures were fixed with 4% PFA (15 min), washed three
times with DPBS (15min), then washed with either TBS1x (low triton
protocol for vesicles specific antibodies) or with TBS1+ (for standard
protein immunocytochemistry) 3 times for 15min and then blocked for 2 h
with TBS++ with or without low triton. Primary antibodies were incubated
for 48 h at 4 °C. Samples were then washed with TBS 1x/TBS+ (15 min)
three times. The blocking was next repeated for 1 h at room temperature
followed by 2 h incubation with the secondary antibodies (all at 1:200
dilution). The antibodies used are listed in Supplementary Table 4 in
Supplementary Information. The samples were then washed with TBS 1x
(15min) three times and then incubated with nuclear staining DAPI
(Invitrogen, dilution 1:5000) for 10min. After washing twice the DAPI with
TBX1x, samples were mounted with PVA:DABCO, dried for 2 h at room
temperature, and stored at 4 °C until imaged. Samples were imaged using
an SP5 confocal microscope (Leica®) and analyzed with FIJI® is Just
ImageJTM®.
Gene expression analysis using Human Neuropathology Panel
50 ng of total RNA per sample was prepared for analysis with a NanoString
Human Neuropathology Panel chip. The assay was performed on an
nCounter SPRINT Analysis System (Sanford Consortium for Regenerative
Medicine Stem Cell Genomics Core, La Jolla) according to the
manufacturer’s instructions. The nSolver software by NanoString was used
to normalize gene expression data. ROSALIND software (OnRamp
Bioinformatics, https://rosalind.onramp.bio/) was then used to interpret
targeted gene expression data and to create heatmaps. Data was then
analyzed by ROSALIND® (https://rosalind.onramp.bio/), with a HyperScale
architecture developed by OnRamp BioInformatics, Inc. (San Diego, CA) to
interpret targeted gene expression data and to create heatmaps. Read
Distribution percentages, violin plots, identity heatmaps, and sample MDS
plots were generated as part of the QC step. The limma R library37 was
used to calculate fold changes and p-values. Clustering of genes for the
final heatmap of differentially expressed genes was done using the PAM
(Partitioning Around Medoids) method using the fpc R library (https://cran.
r-project.org/web/packages/fpc/index.html) that takes into consideration
the direction and type of all signals on a pathway, the position, role, and
type of every gene, etc. Hypergeometric distribution was used to analyze
the enrichment of pathways, gene ontology, domain structure, and other
ontologies. Functional enrichment analysis of pathways, gene ontology,
domain structure, and other ontologies was performed using HOMER38.
Several database sources were referenced for enrichment analysis,
including Interpro39, NCBI40, KEG41,42, MSigDB43, REACTOME44, and
WikiPathways45. Enrichment was calculated relative to a set of background
genes, relevant to the experiment. The transcriptomic data has been
deposited in Gene Expression Omnibus (GEO) of the National Center for
Biotechnology Information and are accessible through GEO Series
accession number SE167335.
Neuronal quantification during differentiation
Immunostaining images were analyzed using Fiji® software to quantify the
percentage of TH/DAPI at day 35, 50, and 80, and TH/FOXA2 and TH/GIRK
at day 50 and the presence of pyknotic nuclei at day 50 and 80. An average
of 5 images was quantified for each ratio, and each differentiation was
performed at least three times.
Neurite quantification
Immunostaining images were analyzed with NeuronJ® software to quantify
number of neurites per neuron and neurite length for TH+ cells. Each
neuron was analyzed in NeuronJ® and each trace was automatically
measured and organized in order to obtain information for every single
cell. Immunostaining images were analyzed with NeuronJ® software to
quantify number of neurites per neuron for MAP2+ cells. An average of
five images and ten neurons per image were analyzed at each timepoint
for TH+ and MAP2+ data for every iPSC-derived line.
Calcium imaging assay
We used calcium fluorescence imaging46–49 to evaluate the differences in
spontaneous activity between healthy and PD neurons. Calcium imaging
allowed the monitoring of a large population of neurons, simultaneously
and non-invasively (Fig. 2). Living neurons were incubated for 30min in a
solution that contained 3ml of the recording medium (EM, consisting of
128mM NaCl, 1 mM CaCl2, 1 mM MgCl2, 45 mM sucrose, 10 mM glucose,
and 0.01 M Hepes; pH 7.4) and 4 µg/ml of the cell-permeant calcium-
sensitive dye Fluo-8-AM. At the end of incubation, cultures were washed
with 2ml of fresh EM to remove residual Fluo-8 and transferred to a glass-
bottom dish (Mattek) filled with EM for imaging. The dish was mounted on
a Zeiss inverted microscope equipped with a CMOS camera (Hamamatsu
Orca Flash 2.8) and an arc lamp for fluorescence. Greyscale images of
spontaneous neuronal activity were acquired at 20 Hz for 15min in a field
of view of 2.8 × 2.1 mm2 that contained between 300 and 700 neurons. A
bright-field image of the monitored region was taken at the end of the
recording session for easier cell identification. Data was then analyzed with
the custom software NETCAL, run on MatLab®, to extract the trains of
neuronal activations, as follows. Regions of Interest (ROIs) corresponding to
cell bodies that exhibited prototypical neuronal morphology were
manually drawn on the bright-field images, and their fluorescence
intensity as a function of time extracted (Fig. 2a). These fluorescence
traces were then inspected to remove non-neuronal signals (either
undifferentiated cells or glia). A Schmitt-trigger method49 was next used
on the fluorescence traces to identify the timing of neuronal activations,
finally procuring the set of spike trains for each neuron. The resulting data
of neuronal network activity was visualized in the form of raster plots.
Collective episodes of coherent activity (network bursts) appeared as the
synchronous activation of a large fraction of the neurons in the network in
a short time window.
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Determination of DA release levels
The supernatant collected from DA neurons differentiated from CTR (SP11),
PD1 (SP12), PD2 (SP13), and isoPD1 (SP12 wt/wt) for 50 and 80 days (D50
and D80), was harvested and kept directly at −80 °C until the moment of
analysis. Before their analysis, medium samples were previously deprotei-
nized with 50 µl of homogenization medium (100mL miliQ H2O, 100mg of
sodium metabisulphite (S-1516, Sigma), 10 mg EDTA-Na (E5134, Sigma),
100mg cysteine (C-4022, Sigma), and 3.5 mL de HClO4 concentrated
(Scharlau, 70%); centrifuged at 15,000 rpm during 30′ at 4 °C and the
supernatant was filtered (Millex-HV 0.45 μm, Millipore) for a posterior HPLC
injection. The concentration of dopamine (DA) in supernatant (SN) samples
was determined by an HPLC system consistent of a Waters 717plus
autosampler (Waters Cromatografia), a Waters 515 pump, a 5 μm particle
size C18 column (100 × 46mm, Kinetex EVO, Phenomenex), and a Waters
2465 amperometric detector set at an oxidation potential of 0.75 V. The
mobile phase consisted of 0.15 M NaH2PO4.H2O, 0.57mM 1-octane sulfonic
acid, 0.5 mM EDTA (pH 2.8, adjusted with phosphoric acid), and 7.4%
methanol and was pumped at 0.9 ml/min. The total sample analysis time
was 50min and the DA retention time was 3.94 min. The detection limit
was 2–3 fmol (injection volume 60 µl). Corresponding dopamine metabo-
lite content was normalized to protein concentration determined
previously by Bradford method detection.
Average neuronal activity and global network activity (GNA)
The average neuronal activity quantified the degree of spontaneous
activity in the recordings and was determined by counting the number of
activations per neuron and minute, averaging afterward across neurons
and realizations of the same line and timepoint. The GNA quantified the
capacity of the network to exhibit collective synchronous events (bursts),
and was determined by, first, counting the neurons that activated together
in a sliding window of 1 s in length (corresponding to 20 image frames)
without repetition and, second, by normalizing the count with the number
of active neurons in the network. GNA thus varied between 0 (no activity)
and 1 (full network activation). Bursts appeared in the GNA data as sharp
peaks. The higher the GNA amplitude, the higher the number of
participating neurons in the burst (Fig. 2c).
Ratio of extreme events of network bursting
They corresponded to those GNA episodes in which neuronal participa-
tion was much higher than average and relatively to control (CTR)
cultures. To compute the number of extreme events, GNA data were
analyzed as follows. First, for each recording, background activity was
determined by iteratively removing all peaks in the GNA signal that
exceed by two standard deviations the average GNA value, procuring a
background activity that was typically around GNA ≅ 0.05 (5% of the
network). The non-background peaks of the recording were then
ascribed as truly bursting episodes, with amplitudes that were typically
above GNA= 0.1. Second, all the peak amplitudes observed in CTR
cultures were pooled together and the average peak amplitude ACTR and
standard deviation SDCTR determined. Then, for each realization and
condition (CTR, isoPD1, PD1, and PD2), those bursting peaks that were
above ACTR+ 2SDCTR were considered as ‘extreme events’. The ‘ratio of
extreme events’ REE was then determined, for each realization, as the
ratio between the number of extreme peaks and the total number of
observed peaks. Since this definition sets the CTR cultures as reference,
some of the CTR realizations exhibited REE close to 0, while PD1 or PD2
realizations exhibited REE close to 1.
Effective connectivity
Since the number of neurons varied among realizations, all connectivity
analyses were carried out in networks with randomly chosen 340 neurons,
the minimum population in all experiments. Also, to ensure that
connectivity and network analyses reflected the impact of bursting
behavior, only those recording with at least 10 bursting events were used
for connectivity inference. Causal relationships among pairs of neuronal
spike trains were inferred using a modified version of the Generalized
Transfer Entropy (GTE)50. Briefly, given a pair of spike trains corresponding
to neurons X and Y, an effective connection was established between
X and Y whenever the information contained in X significantly increased
the capacity to predict future states of Y (Granger causality). For the actual
estimation of the effective connectivity, binarized time series (‘1’ for the
presence of a spike, ‘0’ for absence) were constructed and computed in the
fast implementation of GTE run in MatLab. Instant feedback was present,
and Markov Order was set as 2. The actual GTE estimate was then
compared with those from the joint distribution of all inputs to Y and all
outputs to X, setting a connection as significant whenever the GTE
estimate exceeded the mean+ 1 standard deviations of the joint
distribution. This threshold was considered optimal to capture the effective
interactions among neurons during bursting episodes, which is the key
dynamic characteristic separating CTR and isoPD cultures from PD ones. All
network measures and connectivity statistics were computed with this
threshold condition. However, for visualization purposes only, the GTE data
shown in the functional matrices and network maps were thresholded at
mean+ 2.5 standard deviations, which procured the top 10% strongest
links. In either case, the GTE scores were finally set to 0 (absence of
connection) or 1 (connection present), shaping directed yet unweighted
connectivity matrices. In all network maps, the directionality of the
connections was not shown for clarity. Also, for clarity of language, the
term ‘functional’ was used instead of ‘effective’ throughout the description
of results.
Functional communities
GTE connectivity data was analyzed, for each culture realization, to obtain
the number of functional communities and their interrelation. A functional
community corresponds to groups of neurons that are more connected
within themselves than with the rest of network. They were detected
using a fast implementation of the Louvain’s algorithm on the most
significant connected component (Brain Connectivity Toolbox)51. Com-
munities were visualized as boxes along the diagonal of the functional
connectivity matrices. The strength of a community, i.e., how isolated it is
from the rest of the network, was asserted through the community
statistic Q. The larger Q, the higher the tendency of the network to split
into characteristic communities. Q= 0 corresponds to the situation in
which the network is highly integrated and the only community is the
network itself, while Q= 1 corresponds to the extreme case in which all
neurons are disconnected from one another and there are as many
communities as neurons.
Cumulative distribution of connections and Kullback–Leibler
divergence
The effective connectivity matrix was analyzed to extract the distribution
of connections p(k), i.e., the normalized histogram of the number of
neurons having k connections. This distribution was transformed into the
‘cumulative distribution function’ CDF(k), which provides the probability
that a neuron has many connections less or equal than k. The divergence
between two CDF distributions P and S was quantified through the
Kullback–Leibler divergence DKL PjjSð Þ ¼
P
i P ið Þ ln P ið ÞS ið Þ, using the function
KLDiv.m in MatLab. Significant statistical differences between P and Q were
analyzed using the Kolmogorov–Smirnov test.
In silico model
The model of Compte et al.52 was used to simulate a network of
excitatory, inhibitory, and dopaminergic neurons. The model incorpo-
rated soma and synaptic dynamics as well as noise in the form of
Poissonian trains of excitatory pre-synaptic potentials. Network construc-
tion was set by placing on a bidimensional space the same neurons as
the ones observed experimentally in the form of ROIs, but limited to a
randomly chosen population of 300 neurons, and axons grew using
biologically-realistic rules as described53,54. Simulations were run for the
equivalent of 10 min in the experiments, and 4 realizations were carried
out for each pruning condition (no pruning, 10%, 30, and 50% pruned
neurites). Raster plots of network activity were analyzed identically as in
the experiments to compute the ratio of extreme events, the effective
connective, and CDFs. Full details of the model are provided in
Supplementary Information.
Reporting summary
Further information on research design is available in the Nature Research
Reporting Summary linked to this article.
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